NCT06549517

Brief Summary

The goal of this study is to evaluate the effectiveness of a cognitive training program called Mental Training Tech 24.5 (MTT24.5). The program aims to enhance brain function and neuronal plasticity in adults who do not have any clinical cognitive impairment. This study will help determine if MTT24.5 improves cognitive abilities and affects brain volume and activation. The Main Questions it aims to answer are: Does MTT24.5 improve overall cognitive performance and specific areas like memory, attention, and language skills? What effects does MTT24.5 have on brain volume and activation? How well do participants follow the program, and what are their response patterns? Study Design

  • Researchers will compare the results of participation in the MTT24.5 training versus a control group with no intervention. Participants will be randomly assigned to either the MTT24.5 program or the control group.
  • The study involves adults aged 30 and older from the general population who do not have clinical cognitive impairment.
  • The intervention includes attending 12 weekly in-person sessions, each lasting about 2 hours, for a total of 24.5 hours.
  • The study will assess cognitive performance, brain volume, and activation, as well as monitor adherence to the program and response patterns. Participants will:
  • Engage in the MTT24.5 program or the control condition as assigned.
  • Complete cognitive assessments to measure performance in various domains.
  • Undergo brain imaging to evaluate changes in brain volume and activation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 2, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2023

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

August 3, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

August 12, 2024

Completed
Last Updated

August 14, 2024

Status Verified

August 1, 2024

Enrollment Period

5 months

First QC Date

August 3, 2024

Last Update Submit

August 11, 2024

Conditions

Keywords

ageingcognitive dysfunctioncerebral neuroplasticiy

Outcome Measures

Primary Outcomes (1)

  • Change in Global Cognitive Ability

    The primary study outcome, cognitive ability changes, was assessed through the difference between the post intervention Addenbrooke's Cognitive Examination III (ACE) score and the pre intervention ACE score. This score ranges from 0 to 100. he ACE Score ranges from 0 to 100. A value less than 85 es considered as cognitive moderate impairment.

    immediately after the intervention

Secondary Outcomes (3)

  • Change in memory, and /or attention, and/or verbal fluency, and/or language, and/or visuospatial skills abilities.

    immediately after the intervention

  • Rate of Adherence

    immediately after the intervention

  • Change in Brain Volume and Activation

    immediately after the intervention

Study Arms (2)

Intervention group-MTT24.5

ACTIVE COMPARATOR

Subjects are assigned to 12 cognitive training in-person sessions of the MTT245 program by a validated trainer. Cognitive evaluations are made initially week 1 and at the end of the intervention at week 12.

Behavioral: Cognitive training

Control group

NO INTERVENTION

Subjects are assigned to a controlled arm whereas no intervention were done. They should underwent the same cognitive evaluations than active comparator at week 1 and 12.

Interventions

MTT24.5 consists in the learning of 40 new datas or knowledges, along 24.5 hours distributted on classes or sessions, during which an average of 3.5 new pieces of knowledge are taught and reinforced through training. Participants are trained using 4 techniques assigned to each new piece of information from a total of 100 available techniques. These techniques include the use of non-dominant skills, literacy in Braille for sighted individuals, and performing 5 actions simultaneously. Each technique is designed to aid in the memorization and learning of new knowledge

Also known as: Mental Training Tech 245
Intervention group-MTT24.5

Eligibility Criteria

Age30 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 21 years and above.
  • Ability to understand instructions for the training tasks.
  • Addenbrooke Cognitive Examination score \>70.

You may not qualify if:

  • Planned absences that would hinder participation in the program.
  • Hearing, visual, or motor deficits that would impede participation in the program.
  • History of severe degenerative neurological diseases, as these conditions may significantly impact brain plasticity and cognitive abilities.
  • History of severe psychiatric disorders, as they may influence brain reorganization and complicate the interpretation of results.
  • Unstable treatment or planned changes in medication that may affect brain function and alter results.
  • History of current or recent excessive substance use (within the past 6 months), including alcohol or drugs, as these substances may influence brain function and neuroplasticity.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Espacio Santa Maria

San Isidro, Buenos Aires, 1643, Argentina

Location

Related Publications (8)

  • Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, Brayne C, Burns A, Cohen-Mansfield J, Cooper C, Costafreda SG, Dias A, Fox N, Gitlin LN, Howard R, Kales HC, Kivimaki M, Larson EB, Ogunniyi A, Orgeta V, Ritchie K, Rockwood K, Sampson EL, Samus Q, Schneider LS, Selbaek G, Teri L, Mukadam N. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020 Aug 8;396(10248):413-446. doi: 10.1016/S0140-6736(20)30367-6. Epub 2020 Jul 30. No abstract available.

    PMID: 32738937BACKGROUND
  • Lindenberger U. Human cognitive aging: corriger la fortune? Science. 2014 Oct 31;346(6209):572-8. doi: 10.1126/science.1254403.

    PMID: 25359964BACKGROUND
  • Ball K, Berch DB, Helmers KF, Jobe JB, Leveck MD, Marsiske M, Morris JN, Rebok GW, Smith DM, Tennstedt SL, Unverzagt FW, Willis SL; Advanced Cognitive Training for Independent and Vital Elderly Study Group. Effects of cognitive training interventions with older adults: a randomized controlled trial. JAMA. 2002 Nov 13;288(18):2271-81. doi: 10.1001/jama.288.18.2271.

    PMID: 12425704BACKGROUND
  • Snowdon DA; Nun Study. Healthy aging and dementia: findings from the Nun Study. Ann Intern Med. 2003 Sep 2;139(5 Pt 2):450-4. doi: 10.7326/0003-4819-139-5_part_2-200309021-00014.

    PMID: 12965975BACKGROUND
  • Rebok GW, Ball K, Guey LT, Jones RN, Kim HY, King JW, Marsiske M, Morris JN, Tennstedt SL, Unverzagt FW, Willis SL; ACTIVE Study Group. Ten-year effects of the advanced cognitive training for independent and vital elderly cognitive training trial on cognition and everyday functioning in older adults. J Am Geriatr Soc. 2014 Jan;62(1):16-24. doi: 10.1111/jgs.12607. Epub 2014 Jan 13.

    PMID: 24417410BACKGROUND
  • Feingold A. New Approaches for Estimation of Effect Sizes and their Confidence Intervals for Treatment Effects from Randomized Controlled Trials. Quant Method Psychol. 2019;15(2):96-111. doi: 10.20982/tqmp.15.2.p096.

    PMID: 32775313BACKGROUND
  • Masic V, Secic A, Trost Bobic T, Femec L. Neuroplasticity and Braille reading. Acta Clin Croat. 2020 Mar;59(1):147-153. doi: 10.20471/acc.2020.59.01.18.

    PMID: 32724286BACKGROUND
  • Kotliar C, Olmos L, Koretzky M, Jauregui R, Delia T, Cingolani O. A new program for systematically enhancing cognitive reserve in healthy adults: A pilot randomized active-controlled clinical trial. PLoS One. 2025 Oct 1;20(10):e0331193. doi: 10.1371/journal.pone.0331193. eCollection 2025.

MeSH Terms

Conditions

Cognitive Dysfunction

Interventions

Cognitive Training

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Neurological RehabilitationRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Carol V Kotliar, PhD

    BIO

    PRINCIPAL INVESTIGATOR
  • Carol V Kotliar, PhD

    Institute for Biomedical Research, CONICET

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Multisite, prospective, and open-label study involving two arms. Subjects from the general adult population were randomly assigned to either a cognitive intervention group or a no-intervention control group. The intervention consisted of in-person cognitive training over 12 weeks, with baseline and final cognitive evaluations. A sub-study will investigate neuroimaging changes in brain volume and activation as parameters of neuroplasticity stimulation
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief Clinical Research Laboratory

Study Record Dates

First Submitted

August 3, 2024

First Posted

August 12, 2024

Study Start

March 2, 2023

Primary Completion

August 1, 2023

Study Completion

October 30, 2023

Last Updated

August 14, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will share

At the time of publication, and upon aproval of the request by a scientific board, all IPD that underlie results in a publication will be shared.

Shared Documents
STUDY PROTOCOL, SAP, ANALYTIC CODE
Time Frame
At the time of publication in a peer review journal
Access Criteria
By written request to the PI, accompanied by a letter explaining objectives of the IPD to be shared and research group institution or antecedents of the individual if not an institution.
More information

Locations